SARS-CoV-2 and Multiple Sclerosis: Not All Immune-Depleting DMTs Are Equal or Bad
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs Are Equal or Bad
Ann. Neurol 2020 Jun 01;87(6)794-797, S Amor, D Baker, SJ Khoury, K Schmierer, G GiovanonniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.